Health Science Center's Impact
Stephanie Cannon '06 July 15, 2014 9:07 AM
A new test for tuberculosis (TB) could dramatically improve the speed and accuracy of diagnosis for one of the world’s deadliest diseases, enabling health care providers to report results to patients within minutes.
Jeffrey Cirillo, Ph.D., professor at the Texas A&M Health Science Center College of Medicine, in collaboration with GBDbio, a Texas A&M spinoff company, and investigators at Stanford University, have identified a new chemical compound to spot the bacteria that cause TB with a level of sensitivity that currently takes months to produce; and results of the first human clinical trial data are promising.
Read more at news.tamhsc.edu.
Jeffrey Cirillo, Ph.D., professor at the Texas A&M Health Science Center College of Medicine, in collaboration with GBDbio, a Texas A&M spinoff company, and investigators at Stanford University, have identified a new chemical compound to spot the bacteria that cause TB with a level of sensitivity that currently takes months to produce; and results of the first human clinical trial data are promising.
Read more at news.tamhsc.edu.
505 George Bush Drive
College Station, TX 77840
(979) 845-7514
When Aggies see a need, their energy and their selflessness draw others into the cause, and good things happen.
© 2024 The Association of Former Students of Texas A&M University, All Rights Reserved